POMDOCTOR LIMITED Announces Strategic Upgrade Toward Infrastructure for Predictive Healthcare Data and Services
GUANGZHOU, China, July 2, 2026 /PRNewswire/ -- POMDOCTOR LIMITED (the "Company") (NASDAQ: POM), a leading online medical services platform for chronic diseases in China, today announced a strategic upgrade, officially positioning the Company as a foundational infrastructure provider for predictive healthcare data and services. The strategic upgrade reflects the Company's continued evolution from a traditional online healthcare platform toward...
SK bioscience Launches AI-Powered Initiative to Reduce Uncertainty in Vaccine-Development Decisions
SK bioscience was selected to lead the Gates Foundation-funded ROTOR project, establishing a global collaboration framework. SK bioscience, PATH, Slalom, and SK AX will jointly develop an AI-powered platform for evidence-based clinical development decision-making. The project will support next-generation injectable rotavirus vaccine development and contribute to expanding vaccine access in...
Hong Kong Life Receives the Certifications of “Hong Kong Registration – Silver-Friendly Financial Products” Presented by Hong Kong Quality Assurance Agency for Multiple Outstanding Insurance Products
HONG KONG, July 2, 2026 /PRNewswire/ -- Hong Kong Life Insurance Company Limited ("Hong Kong Life") has been awarded the "Hong Kong Registration – Silver-Friendly Financial Products" certification presented by Hong Kong Quality Assurance Agency ("HKQAA") for its outstanding insurance products. This recognition affirms Hong Kong Life's exceptional performance in product development, service support and customer care, providing...
SOCO® Launches Small-Pack Solidification Solutions for Healthcare and Emergency Sanitation Applications
LOS ANGELES, July 2, 2026 /PRNewswire/ -- As healthcare facilities, portable sanitation providers and emergency response organizations seek safer methods for liquid waste management, SOCO® announced the launch of its small-pack solidification solutions designed for medical liquid waste handling and outdoor emergency sanitation applications. The new solutions rapidly convert compatible liquid waste into stable gel form, addressing critical...
Yidu Tech Achieves Its First Full-Year Profit: FY2026 Net Profit Reaches RMB 78.8 Million, with Positive Operating Cash Flow in the Second Half
BEIJING, July 2, 2026 /PRNewswire/ -- On July 2, Yidu Tech (02158.HK), a leading AI healthcare company, held its annual results presentation to review its financial performance for the fiscal year ended March 31, 2026 ("FY2026"). During the reporting period, the Company achieved its first full-year profitability, with net profit reaching RMB 78.8 million, exceeding the upper end of...
Insilico Medicine Announces Collaboration with Takeda to Advance Strategic AI Drug Discovery
Partnership to leverage Pharma.AI platform for novel drug candidates across Takeda's therapeutic areas CAMBRIDGE, Mass., July 2, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico" HKEX:3696), a leader in clinical-stage generative AI for drug discovery, today announced a strategic collaboration agreement with Takeda to use its proprietary end-to-end platform, Pharma.AI, to advance drug candidates across the company's therapeutic areas. The collaboration...
MORE YOUNG PEOPLE STRUGGLE WITH HAIR LOSS: REGAINE®* LEADS THE CHARGE FOR HAIR SCIENCE RESEARCH
New findings show hair loss affecting more young people in APAC Social media is driving earlier awareness of hair loss REGAINE® reaffirms commitment to research and innovation to meet evolving hair loss landscape at the 14th World Congress of Hair Research (WCHR) Study conducted by renowned Korean professors on the...
Ribo and Madrigal Reach First Major Milestone in Advancing Novel siRNA Therapies for MASH
SUZHOU, China and MÖLNDAL, Sweden, July 2, 2026 /PRNewswire/ -- Suzhou Ribo Life Science Co., Ltd. (06938.HK), and its subsidiary Ribocure Pharmaceuticals AB (collectively referred to as "Ribo"), in collaboration with Madrigal Pharmaceuticals, Inc. (Madrigal, NASDAQ: MDGL) announce the successful achievement of the first candidate drug nomination milestone within their siRNA...
Abbisko Therapeutics and AstraZeneca Enter a Strategic Collaboration to Conduct the Clinical Trial of Lumipodlin (ABSK043), a First-in-Class Oral PD-L1 Inhibitor, in Combination with TAGRISSO® for NSCLC
SHANGHAI, July 2, 2026 /PRNewswire/ -- Abbisko Therapeutics Co., Ltd. ("Abbisko Therapeutics" hereafter, HKEX code: 02256.HK) today announced that it has entered into a strategic collaboration agreement with AstraZeneca (LSE/STO/NYSE: AZN) to jointly advance the clinical development of a novel IO-TKI combination therapy for non-small cell lung cancer (NSCLC). As a...
Nona Biosciences and Lonza Enter Strategic Collaboration to Develop Best-in-Class Single-Domain Antibody-Based BBB-Crossing Technology for CNS Diseases
CAMBRIDGE, Mass., July 2, 2026 /PRNewswire/ -- Nona Biosciences ("Nona"), a global biotechnology company advancing biologics discovery and development through innovative technology platforms, today announced a strategic collaboration with Lonza to develop best-in-class single-domain antibody–based blood-brain barrier (BBB)-crossing technology for central nervous system (CNS) diseases. This collaboration...
